Schizophrenia

Building on previous findings, a new study examines the discovery of a key modulator of the DISC1 gene that can impact various stages of brain development.

The majority of patients who are treated in non-psychiatric hospitals for psychiatric issues are cared for in hospital-based psychiatric units, not general medicine beds, or "scatter beds."

This symposium focused on presenting the most recent results of key projects conducted to evaluate the effects of early detection/intervention strategies.

How race, ethnicity, and culture affect bipolar disorder; dental care and L-lysine treatment in schizophrenia.

Ten of the latest investigations into schizophrenia and bipolar disorder.

Various approaches for different stages of schizophrenia and intervention adjustments based on individual needs were discussed.

New research reveals that areas of the brain that regulate communication may also be impacted by the medications commonly used for schizophrenia.

An international study, led by University of Montreal researchers Julie Gauthier and Guy Rouleau, reveals that gene mutations in the SHANK3 gene may predispose individuals to schizophrenia.

Raloxifene could become a new treatment option for post-menopausal women with schizophrenia.

A lack of the neurotransmitter gamma-aminobutyric acid may be the cause of cognitive problems in patients with schizophrenia.

This study explored the relationship between depressive symptoms in newly-admitted schizophrenia patients and their well-being.

This online journal abstract discusses the impact that being stereotypically labeled as mentally ill has on schizophrenia patients' behavior in a social setting.

This study will evaluate familial risk factors for schizophrenia.

This trial aims to determine if culturally based family therapy intervention will improve treatment outcomes in patients with schizophrenia.

This activity features three case studies, which are used to describe typical cases that would lead to a diagnosis of early-onset schizophrenia.

This activity discusses the typical signs of early-onset schizophrenia-spectrum disorders.

New findings from a 25-year study show that patients with schizophrenia have a mortality risk that is two to three times that of the general population.

Although the symptoms of schizophrenia often do not appear until early adulthood, new research may provide insight into the development of the disease, which may occur as early as in the womb.

Duke University researchers have discovered that adults with schizophrenia may exhibit a pattern during childhood of cognitive problems, including difficulties with verbal reasoning, working memory, attention and processing speed.

Researchers at the University of North Carolina-Chapel Hill have discovered how the 22q11 gene deletion is associated with changes in brain development that affect how the circuit system in the brain is put together.

The results of a new clinical trial of the schizophrenia drug Saphris (asenapine) has shown that the drug is effective at significantly extending both the time to relapse or impending relapse and the time to treatment discontinuation.

British researchers in the Department of Psychiatry at the University of Oxford have demonstrated an association between schizophrenia and violence, and more importantly, that the association is greatly increased with drug and alcohol abuse.

A significant portion of the genetic basis of schizophrenia can be traced to the cumulative effect of a large number of common genetic variants, researchers have discovered.

Study results show that cognitive impairments are "reliably and broadly present" by the first episode of schizophrenia which makes work, studying, and social interactions difficult for those suffering from the disorder.

A variation in genetic expression may lead to an increased risk for schizophrenia, according to new research from Rutgers University.

An analysis of the DISC1 gene, which plays a role in mental illness, may lead to improved methods for prescribing targeted medications.

Study results reveal that the gene DISC1—shown "to help brain neuronal cells migrate to their correct positions and to help new neurons grow in the developing brain"—directly inhibits GSK3B activity.

New research has discovered how the toxoplasmosis parasite may activate the development of schizophrenia and other bipolar disorders.

The inheritable aspect of schizophrenia may be due to, in large part, structural changes in DNA called copy number variants, not more common genetic variants that have been the focus in previous studies.

Certain antipsychotics, particularly olanzapine and quetiapine, are associated with an increased risk of coronary heart disease (CHD), whereas others—like perphenazine, risperidone and ziprasidone—lead to a decreased risk of CHD, results of a new study in the Journal of Schizophrenia Research show.